SCHEMBL28019458

SCHEMBL28019458

CC(Br)c1cccc(C(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 2/20 0.39
PGK2 P07205 2/20 0.39
NOTUM Q6P988 1/20 0.35
KIF11 P52732 1/20 0.34
RET P07949 1/20 0.34
DAO P14920 1/20 0.33
P2RX7 Q99572 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MDM4 O15151 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
TYR P14679 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8897527 0.90 HDAC4 (0.37) PGK1PGK2P2RX7KDM4EMDM4
SCHEMBL1539046 0.88 PGK1 (0.38) PGK1PGK2P2RX7KDM4EMDM4
SCHEMBL1538725 0.84 PGK1 (0.48) PGK1PGK2NOTUMKIF11DAO
SCHEMBL28434776 0.83 HDAC4 (0.47) NOTUMKIF11KDM4EMDM4ALDH1A1
SCHEMBL7962498 0.83 PGK1 (0.40) PGK1PGK2NOTUMKIF11DAO
SCHEMBL12028994 0.80 HDAC4 (0.48) PGK1PGK2NOTUMKIF11KDM4E
SCHEMBL508509 0.79 ACHE (0.44) HDAC4
SCHEMBL30076024 0.79 ACHE (0.44) HDAC4
SCHEMBL27700785 0.77 TRPV4 (0.33) NOTUMKIF11DAO
SCHEMBL25091414 0.76 PGK1 (0.39) PGK1PGK2NOTUMKIF11RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105555783-A Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core NOVARTIS AG 2016-05-04 CN disclosed
CN-105073744-A Novel heterocyclic compounds as bromodomain inhibitors RVX THERAPEUTICS INC 2015-11-18 CN disclosed